Ross Summer, MD
Professor of Medicine
Chief of Section of Allergy, Pulmonary & Critical Care Medicine
Director, ILD Program
Contact Information
Professor of Medicine
Chief of Section of Allergy, Pulmonary & Critical Care Medicine
Director, ILD Program
Education
Medical School
Louisiana State University - New Orleans - 1996
Residency
Johns Hopkins University Hospital
Fellowship
Boston University Medical Center Hospital
Publications
- Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
- Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Board Certification
Critical Care Medicine
Pulmonary Disease
Internal Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Research & Clinical Interests
Dr. Ross Summer is a board-certified pulmonary and critical care physician and an NIH-funded investigator. Dr. Summer completed his residency training in internal medicine at Johns Hopkins Hospital in Baltimore, MD and then went on to complete a four-year pulmonary and critical care fellowship at Boston University. Dr. Summer spends his time attending on the pulmonary consult service and in the medical intensive care unit at Thomas Jefferson University Hospital in Center City Philadelphia. In addition, Dr. Summer spends a significant portion of his time overseeing a basic science program, whose major focus is to understand the molecular mechanisms contributing to the pathogenesis of Acute Respiratory Distress syndrome (ARDS) and Idiopathic Pulmonary Fibrosis (IPF).